House Bill 4158
116th Congress(2019-2020)
CURE High Drug Prices Act
Introduced
Introduced in House on Aug 2, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4158
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
August 2, 2019
08/05/2019
Referred to the Subcommittee on Health.
08/02/2019
Referred to the House Committee on Energy and Commerce.
08/02/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:50:11 PM